The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Orthotopic models of cancer for preclinical drug evaluation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Organ targeting In vivo using phage display peptide libraries
Pasqualini, R., & Ruoslahti, E. (1996) · Nature · doi:10.1038/380364a0 · Cited by 1,221
Johnson, J. I., Decker, S., Zaharevitz, D., Rubinstein, L. V., Venditti, J. M., Schepartz, S., Kalyandrug, S., Christian, M., Arbuck, S., Hollingshead, M., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1796 · Cited by 856
Orthotopic Models are Necessary to Predict Therapy of Transplantable Tumors in Mice
Killion, J. J., Radinsky, R., & Fidler, I. J. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1006140513233 · Cited by 430
Chishima, T., Miyagi, Y., Wang, X., Yamaoka, H., Shimada, H., Moossa, A. R., & Hoffman, R. M. (1997) · PubMed · Cited by 284
Wagn, X. (1994) · Cancer Research · Cited by 256
Endothelial cell proliferation as a novel approach to targeting tumour therapy
Denekamp, J. (1982) · British Journal of Cancer · doi:10.1038/bjc.1982.16 · Cited by 249
Anticancer Drug Development: Preclinical Screening, Clinical Trials and Approval
Selwood, D. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602070 · Cited by 238
Human Tumor Xenograft Models in NCI Drug Development
Plowman, J., Dykes, D. J., Hollingshead, M., Simpson-Herren, L., & Alley, M. C. (1997) · Anticancer Drug Development Guide · doi:10.1007/978-1-4615-8152-9_6 · Cited by 220
In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug
Grosios, K., Holwell, S. E., McGown, A. T., Pettit, G. R., & Bibby, M. C. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6692174 · Cited by 213
Self-citationAnimal models of bone metastasis
Rosol, T. J., Tannehill-Gregg, S. H., LeRoy, B. E., Mandl, S., & Contag, C. H. (2003) · Cancer · doi:10.1002/cncr.11150 · Cited by 211
Fidler, I. J. (1991) · Cancer and Metastasis Review · doi:10.1007/bf00050794 · Cited by 183
Modulation of tumor cell response to chemotherapy by the organ environment
Fidler, I. J., Wilmanns, C., Staroselsky, A., Radinsky, R., Dong, Z., & Fan, D. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00689637 · Cited by 165
Chemical modification of tumour blood flow
Jirtle, R. L. (1988) · International Journal of Hyperthermia · doi:10.3109/02656738809016490 · Cited by 133
Biology of human colon cancer metastasis
Gutman, M., & Fidler, I. J. (1995) · World Journal of Surgery · doi:10.1007/bf00308631 · Cited by 133
Lin, W., Pretlow, T. P., Pretlow, T. G., & Culp, L. A. (1990) · PubMed · Cited by 106
Fidler, I. J., Naito, S., & Pathak, S. (1990) · Cancer and Metastasis Reviews · doi:10.1007/bf00046341 · Cited by 104
Dong, Z., Radinsky, R., Fan, D., Tsan, R., Bucana, C. D., Wilmanns, C., & Fidler, I. J. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.12.913 · Cited by 101
Is the P388 murine tumor no longer adequate as a drug discovery model?
Corbett, T. H., Valeriote, F. A., & Baker, L. H. (1987) · Investigational New Drugs · doi:10.1007/bf00217664 · Cited by 81
Abnormal Response of Tumor Vasculature to Vasoactive Drugs23
Chan, R. C., Babbs, C. F., Vetter, R. J., et al. (1984) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/72.1.145 · Cited by 73
Therapeutic Index: A Vital Component in Selection of Anticancer Agents for Clinical Trial
Double, J. A., & Bibby, M. C. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.13.988 · Cited by 63
Self-citationPotentiation of EO9 anti-tumour activity by hydralazine
Bibby, M. C., Sleigh, N. R., Loadman, P. M., & Double, J. A. (1993) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80218-7 · Cited by 16
Self-citation
Cited by
Cancer treatments: Past, present, and future
Sonkin, D., Thomas, A., & Teicher, B. A. (2024) · Cancer Genetics · doi:10.1016/j.cancergen.2024.06.002 · Cited by 548
Murine Models to Evaluate Novel and Conventional Therapeutic Strategies for Cancer
Talmadge, J. E., Singh, R. K., Fidler, I. J., & Raz, A. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060929 · Cited by 468
Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer
Patra, C. R., Bhattacharya, R., Mukhopadhyay, D., & Mukherjee, P. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.007 · Cited by 458
Hydrodynamic Transfection for Generation of Novel Mouse Models for Liver Cancer Research
Chen, X., & Calvisi, D. F. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.12.002 · Cited by 434
Vaccines for tumour prevention
Lollini, P.-L., Cavallo, F., Nanni, P., & Forni, G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1815 · Cited by 340
Metadata
- Authors
- Bibby, M. C.
- Venue
- European Journal of Cancer
- Publisher
- Elsevier BV
- Published
- 2004-04
- Volume
- 40
- Issue
- 6
- Pages
- 852-857
- ISSN
- 0959-8049 (ISSN-L)
- OpenAlex
- W1258890488
- Cited by
- 315
- References
- 21
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.